These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 33472660)

  • 1. Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer.
    Zhao M; Zhao L; Yang H; Duan Y; Li G
    Radiat Oncol; 2021 Jan; 16(1):17. PubMed ID: 33472660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-task reconstruction network for synthetic diffusion kurtosis imaging: Predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    Ma Q; Liu Z; Zhang J; Fu C; Li R; Sun Y; Tong T; Gu Y
    Eur J Radiol; 2024 May; 174():111402. PubMed ID: 38461737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MRI for evaluation of pathological response to the neoadjuvant chemo-immunotherapy in resectable non-small-cell lung cancer.
    Bao X; Bian D; Yang X; Wang Z; Shang M; Jiang G; Shi J
    Eur Radiol; 2023 Dec; 33(12):9182-9193. PubMed ID: 37382618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Multipurpose Usage of Diffusion-Weighted MRI in Rectal Cancer.
    Yacheva A; Dardanov D; Zlatareva D
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138265
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of treatment response by multiparametric MR imaging in locally advanced rectal tumors following neoadjuvant chemotherapy.
    Fidan M; Nural MS; Çamlıdağ İ; Yürüker SS; Meydan BC
    Abdom Radiol (NY); 2024 Jun; ():. PubMed ID: 38822855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy.
    Galbán CJ; Ma B; Malyarenko D; Pickles MD; Heist K; Henry NL; Schott AF; Neal CH; Hylton NM; Rehemtulla A; Johnson TD; Meyer CR; Chenevert TL; Turnbull LW; Ross BD
    PLoS One; 2015; 10(3):e0122151. PubMed ID: 25816249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent diffusion coefficient as an effective index for the therapeutic efficiency of brain chemoradiotherapy for brain metastases from lung cancer.
    Liu K; Ma Z; Feng L
    BMC Med Imaging; 2018 Sep; 18(1):30. PubMed ID: 30223786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Value of Apparent Diffusion Coefficient of Readout Segmentation of Long Variable Echo Trains and Correlation With Ki-67 Expression in Distal Rectal Cancer.
    Pan YN; Gu MY; Mao QL; Wang HY; Liang YC; Zhang L; Tang GY
    J Comput Assist Tomogr; 2024 May-Jun 01; 48(3):361-369. PubMed ID: 38110307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computed Diffusion-Weighted Images of Rectal Cancer: Image Quality, Restaging, and Treatment Response after Neoadjuvant Therapy.
    Xia Y; Zhu L; Cai G; Du L; Wang L; Feng W; Fu C; Ma Q; Dong Y; Pan Z; Yan F; Shen H; Li W; Zhang H
    J Magn Reson Imaging; 2024 Jan; 59(1):297-308. PubMed ID: 37165908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer.
    Hammarström K; Nunes L; Mathot L; Mezheyeuski A; Lundin E; Korsavidou Hult N; Imam I; Osterlund E; Sjöblom T; Glimelius B
    Int J Cancer; 2024 Jul; 155(1):40-53. PubMed ID: 38376070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor DNA detection after neoadjuvant treatment and surgery predicts recurrence in patients with early-stage and locally advanced rectal cancer.
    Hofste LSM; Geerlings MJ; von Rhein D; Rütten H; Westenberg AH; Weiss MM; Gilissen C; Hofste T; van der Post RS; Klarenbeek BR; de Wilt JHW; Ligtenberg MJL;
    Eur J Surg Oncol; 2023 Jul; 49(7):1283-1290. PubMed ID: 36740555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic insufficiency fractures and pelvic bone metastases after neoadjuvant (chemo)radiotherapy for rectal cancer.
    Rijpma-Jacobs L; van der Vlies E; Meek DB; Bollen TL; Siersema PD; Weusten BLAM; Intven M; van Lelyveld N; Los M
    Acta Oncol; 2023 Oct; 62(10):1295-1300. PubMed ID: 37656773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-chemo-radiotherapy response and pseudo-progression evaluation on glioma cell types by multi-parametric magnetic resonance imaging: a prospective study.
    Zamanian M; Abedi I; Danazadeh F; Amouheidari A; Shahreza BO
    BMC Med Imaging; 2023 Nov; 23(1):176. PubMed ID: 37932656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Texture analysis of apparent diffusion coefficient maps: can it identify nonresponse to neoadjuvant chemotherapy for additional radiation therapy in rectal cancer patients?
    Wu Q; Yi Y; Lai B; Li J; Lian Y; Chen J; Wu Y; Wang X; Cao W
    Gastroenterol Rep (Oxf); 2024; 12():goae035. PubMed ID: 38651169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and
    Uutela A; Ovissi A; Hakkarainen A; Ristimäki A; Lundbom N; Kallio R; Soveri LM; Salminen T; Ålgars A; Halonen P; Ristamäki R; Nordin A; Blanco Sequeiros R; Rinta-Kiikka I; Lantto E; Virtanen J; Pääkkö E; Liukkonen E; Saunavaara J; Ryymin P; Lammentausta E; Osterlund P; Isoniemi H;
    ESMO Open; 2021 Aug; 6(4):100208. PubMed ID: 34325107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer.
    He X; Wang Z; Zhou Y; Feng Y
    Front Oncol; 2023; 13():1132186. PubMed ID: 37064088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of clinical nature, treatment and survival of locally recurrent rectal cancer: Comparative analysis of two national cross-sectional cohorts.
    van Geffen EGM; Langhout JMA; Hazen SJA; Sluckin TC; van Dieren S; Beets GL; Beets-Tan RGH; Borstlap WAA; Burger JWA; Horsthuis K; Intven MPW; Aalbers AGJ; Havenga K; Marinelli AWKS; Melenhorst J; Nederend J; Peulen HMU; Rutten HJT; Schreurs WH; Tuynman JB; Verhoef C; de Wilt JHW; Marijnen CAM; Tanis PJ; Kusters M; On Behalf Of The Dutch Snapshot Research Group
    Eur J Cancer; 2024 May; 202():114021. PubMed ID: 38520925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Multiple MRI Parameters Related to Signal Intensity and Volume for Predicting Response to Neoadjuvant Chemoradiotherapy by Patients with Locally Advanced Rectal Cancer.
    Tan Z; Xie L; Cheng L; Lin Z; Zhang L; Han P; Li X
    Curr Med Imaging; 2023 Nov; ():. PubMed ID: 38031786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of the oxidative stress for patients receiving neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Serbanescu GL; Gruia MI; Bara M; Anghel RM
    J Med Life; 2017; 10(1):99-103. PubMed ID: 28255388
    [No Abstract]   [Full Text] [Related]  

  • 20. The Impact on Survival of Neoadjuvant Treatment Interruptions in Locally Advanced Rectal Cancer Patients.
    Lișcu HD; Antone-Iordache IL; Atasiei DI; Anghel IV; Ilie AT; Emamgholivand T; Ionescu AI; Șandru F; Pavel C; Ultimescu F
    J Pers Med; 2024 Feb; 14(3):. PubMed ID: 38541008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.